Destination Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Destination Wealth Management's NVO Position: Q3 2026 in Review
Destination Wealth Management reduced its Novo Nordisk (NVO) stake by 9.4% in Q3 2026, selling an estimated $173K and leaving 36,181 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #153.
Destination Wealth Management first reported a position in NVO in Q1 2015 and has held it in 29 quarters since. The position peaked at $21.4M in Q2 2024. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Destination Wealth Management held 36,181 shares of Novo Nordisk worth $1.37M as of Q3 2026.
- Destination Wealth Management sold 3,761 Novo Nordisk shares in Q3 2026, an estimated $173K.
- Novo Nordisk made up 0.03% of Destination Wealth Management's portfolio in Q3 2026, its #153 holding.
- Destination Wealth Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 29 quarters since.
- Destination Wealth Management's Novo Nordisk position peaked at $21.4M in Q2 2024.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Destination Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.